ArticleJCEM case reports2026
Apparent vitamin D intoxication due to paraprotein interference.
Article in JCEM case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A 76-year-old man presented shortly after knee arthroplasty with malaise, nausea, and severe parathyroid hormone-independent hypercalcemia. Initial laboratory evaluation demonstrated a markedly elevated 25-hydroxyvitamin D concentration (>250 nmol/L [>100 ng/mL]; reference >50 nmol/L [>20 ng/mL]), suggestive of vitamin D intoxication. However, this diagnosis appeared implausible because the patient used only 400 IU cholecalciferol daily, serum phosphate remained normal, and several Calcium elevation, Renal dysfunction, Anemia and Bone disease features suggested an underlying plasma cell disorder. Further evaluation confirmed symptomatic immunoglobulin A kappa (IgA-κ) multiple myeloma. Repeat measurement of 25-hydroxyvitamin D by liquid chromatography-tandem mass spectrometry (LC-MS/MS) demonstrated a normal concentration (92 nmol/L [36.8 ng/mL]), confirming analytical interference. The falsely elevated result was reproduced in an independent reference laboratory, and 25-hydroxyvitamin D normalized following successful antimyeloma therapy in parallel with a marked reduction in paraprotein concentration. This case highlights the importance of integrating laboratory findings with clinical reasoning and confirms the value of LC-MS/MS in patients with clinically implausible vitamin D concentrations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.